MicroRNAs in Pathogenesis, Diagnosis, and Treatment of Gastroesophageal Cancers

被引:162
|
作者
Song, Jee Hoon [1 ]
Meltzer, Stephen J. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
关键词
Noncoding RNA; MicroRNA; Esophageal Carcinoma; Gastric Carcinoma; INHIBITS CELL-PROLIFERATION; HUMAN GASTRIC-CANCER; TUMOR-SUPPRESSOR; CIRCULATING MICRORNAS; TRANSCRIPTION FACTORS; DOWN-REGULATION; MIR-200; FAMILY; MESENCHYMAL TRANSITION; EPIGENETIC REGULATION; MULTIDRUG-RESISTANCE;
D O I
10.1053/j.gastro.2012.05.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of gastroesophageal cancers is increasing each year, but despite much research, their molecular mechanisms are incompletely understood. microRNAs (miRNAs) are noncoding RNAs that have been associated with gastroesophageal carcinogenesis. We review the involvement of miRNAs in gastric and esophageal cancers and their mechanisms of regulation, effects on gene expression, and biological functions. Many miRNAs are dysregulated in gastroesophageal cancer cells via alterations in transcription, epigenetic features, or copy number of the genes that encode them. Each type of gastroesophageal tumor has a unique gene expression profile. miRNAs contribute to gastroesophageal carcinogenesis by altering expression of oncogenes and tumor suppressors to affect cell proliferation, apoptosis, and motility and invasion. A number of miRNAs, including circulating miRNAs, have been associated with tumor type or stage, or patient survival, and might be developed as diagnostic or prognostic markers. Greater understanding of the roles of miRNAs in gastroesophageal carcinogenesis could provide insights into the mechanisms of tumor development and identify therapeutic targets.
引用
收藏
页码:35 / U543
页数:15
相关论文
共 50 条
  • [1] The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers
    Wilmott, James S.
    Zhang, Xu Dong
    Hersey, Peter
    Scolyer, Richard A.
    PATHOLOGY, 2011, 43 (06) : 657 - 671
  • [2] Gastroesophageal reflux: Pathogenesis, diagnosis, and treatment
    Zeiter, DK
    Hyams, JS
    ALLERGY AND ASTHMA PROCEEDINGS, 1999, 20 (01) : 45 - 49
  • [3] Gastroesophageal reflux (pathogenesis, diagnosis, treatment)
    Kalinin, AV
    TERAPEVTICHESKII ARKHIV, 1996, 68 (08) : 71 - 75
  • [4] MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
    Pisarello, Maria Jose Lorenzo
    Loarca, Lorena
    Ivanics, Tommy
    Morton, Leslie
    LaRusso, Nicholas
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (09): : 1688 - 1712
  • [5] Hepatobiliary Cancers: Progress in Diagnosis, Pathogenesis, and Treatment
    Pant, Kishor
    Gradilone, Sergio A.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [6] MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment
    Xu, Junhua
    Linneman, John
    Zhong, Yanfeng
    Yin, Haoyang
    Xia, Qinyi
    Kang, Kang
    Gou, Deming
    BIOMOLECULES, 2022, 12 (04)
  • [7] Apoptotic functions of microRNAs in pathogenesis, diagnosis, and treatment of endometriosis
    Mona Taghavipour
    Fatemeh Sadoughi
    Hamed Mirzaei
    Bahman Yousefi
    Bahram Moazzami
    Shahla Chaichian
    Mohammad Ali Mansournia
    Zatollah Asemi
    Cell & Bioscience, 10
  • [8] Apoptotic functions of microRNAs in pathogenesis, diagnosis, and treatment of endometriosis
    Taghavipour, Mona
    Sadoughi, Fatemeh
    Mirzaei, Hamed
    Yousefi, Bahman
    Moazzami, Bahram
    Chaichian, Shahla
    Mansournia, Mohammad Ali
    Asemi, Zatollah
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [9] MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment
    Bienertova-Vasku, Julie
    Novak, Jan
    Vasku, Anna
    JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION, 2015, 9 (03) : 221 - 234
  • [10] MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment
    Shah, Nirav R.
    Chen, Hexin
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (02): : 48 - 60